セッション詳細
[O5]Oral Presentations 5
2025年3月18日(火) 13:30 〜 14:50
神戸国際会議場 メインホール(1F)
Presentations 2 - 8 in this session are candidates for the Oral Presentation Award for Early-career Researchers
[O5-01]Impact of restoring a host intrinsic immune response by disabling a viral evasion mechanism on viral pathogenicity
*Yasushi Kawaguchi1 (1. The University of Tokyo Pandemic Preparedness, Infection and Advanced Research (Japan))
[O5-02E]Protective mechanisms of human monoclonal Antibodies cross-reactive against antigenically divergent influenza H3HA
*Shiho Chiba1,2,3, Yoshihiro Kawaoka1,2,3,4 (1. The University of Tokyo (Japan), 2. University of Wisconsin-Madison (United States of America), 3. Institute of Medical Science, the University of Tokyo (Japan), 4. National Center for Global Health and Medicine Research Institute (Japan))
[O5-03E]Development of a live-attenuated vaccine candidate against severe fever with thrombocytopenia syndrome by a reverse genetic system.
*Rokusuke Yoshikawa1,2, Yasuteru Sakurai1,2, Jiro Yasuda1,2 (1. Institute of Tropical Medicine (NEKKEN), Nagasaki University (Japan), 2. National Research Center for the Control and Prevention of Infectious Diseases, Nagasaki University (Japan))
[O5-04E]Optimization of Single-Round Infectious Rotavirus Vectors as Oral Vaccine Platforms
*Tomohiro Kotaki1, Yuta Kanai1, Megumi Onishi1, Yasutaka Enoki1, Shohei Minami1, Zelin Chen1, Katsuhisa Hirai1, Takeshi Kobayashi1,2,3 (1. Research Institute for Microbial Diseases, Osaka University (Japan), 2. Center for Infectious Disease Education and Research, Osaka University (Japan), 3. Center for Advanced Modalities and DDS, Osaka University (Japan))
[O5-05E]SARS-CoV-2 Spikeタンパク質のS2ドメインに対する中和抗体の作用機序の解析
Identification of a broadly neutralizing antibody against the SARS-CoV-2 Spike S2 domain
*Mizuki Yamamoto1, Yoko Hirayama1, Jun-ichiro Inoue2, Yasushi Kawaguchi1,2,3, Jin Gohda1 (1. Research Center for Asian Infectious Diseases, The Institute of Medical Science, The University of Tokyo (Japan), 2. The University of Tokyo Pandemic preparedness, Infection and Advanced research center (UTOPIA), The University of Tokyo (Japan), 3. Division of Molecular Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo (Japan))
[O5-06E]単純ヘルペスウイルス感染における金属トランスポーターの役割
Role of a Metal Transporter in Herpes Simplex Virus Infection
*Kosuke Takeshima1, Yuhei Maruzuru1, Naoto Koyanagi1, Akihisa Kato1, Yasushi Kawaguchi1 (1. The University of Tokyo, The Institute of Medical Science (Japan))
[O5-07E]Vaccine delivery technology using bacterial-derived extracellular vesicles
*Aya Ishizaka1, Taketoshi Mizutani2, Michiko Koga1, Hiroshi Yotsuyanagi1 (1. Institute of Medical Science, The University of Tokyo (Japan), 2. National Institute of Infectious Diseases (Japan))
[O5-08E]Pathogenicity of different genotypes of clade 2.3.4.4b H5N1 high pathogenicity avian influenza virus in a mammalian model
*Shintaro Shichinohe1, Takahiro Hiono2,3,4, Makoto Shimooka1, Norikazu Isoda2,3,4, Yoshihiro Sakoda2,3,4,5, Tokiko Watanabe1,6,7 (1. Research Institute for Microbial Diseases, Osaka University (Japan), 2. Laboratory of Microbiology, Department of Disease Control, Faculty of Veterinary Medicine, Hokkaido University (Japan), 3. International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University (Japan), 4. One Health Research Center, Hokkaido University (Japan), 5. Hokkaido University Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University (Japan), 6. Center for Infectious Disease Education and Research (CiDER), Osaka University (Japan), 7. Center for Advanced Modalities and DDS (CAMaD), Osaka University (Japan))